ArticleEndocrine, metabolic & immune disorders drug targets2026
Therapeutic Potential of Phellodendrine/ Atractylenolide-I Combination in Rheumatoid Arthritis: Targeting Neutrophil Apoptosis through LTB4/BLT1 Pathway Suppression
Zhifang Qin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.